Postmarketing clinical study on AG-1749-clinical study on non-erosive reflux disease
Phase 4
- Conditions
- on-erosive reflux disease
- Registration Number
- JPRN-jRCT1080221028
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
1.Subjects who have repeated acid reflux symptoms(chest burn or water brash)for two days or more in a week for 3 weeks prior to the running period.
2.Subjects shown by endoscopy not to have erosive or ulcerative esophagitis
3.Subjects have given written informed consent to participate in this study.
Exclusion Criteria
1.Subjects complicated with acute gastritis or chronic gastritis in the acute phase of worsening.
2.Subject with a history of surgery (such as upper gastrointestinal tract dissection or vagotomy) that affects gastric acid secretion.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method